关注
Hyejoo Lee
Hyejoo Lee
其他姓名Hye Joo Lee
在 skku.edu 的电子邮件经过验证
标题
引用次数
年份
A validation study of the Inbrain CST: a tablet computer-based cognitive screening test for elderly people with cognitive impairment
J Chin, H Lee, J Yun, BH Lee, J Park, J Yeom, DS Shin, DL Na
Journal of Korean Medical Science 35 (34), 2020
172020
Amyloid positivity in the Alzheimer/subcortical-vascular spectrum
SH Kang, ME Kim, H Jang, H Kwon, H Lee, HJ Kim, SW Seo, DL Na
Neurology 96 (17), e2201-e2211, 2021
242021
Anatomic characteristics of supraorbital foramina in Korean using three-dimensional model
SW Woo, HJ Lee, FS Nahm, PB Lee, EJ Choi
The Korean journal of pain 26 (2), 130, 2013
252013
Association between APOE ε2 and Aβ burden in patients with Alzheimer- and vascular-type cognitive impairment
JS Lee, H Lee, S Park, Y Choe, YH Park, BK Cheon, A Hahn, ...
Neurology 95 (17), e2354-e2365, 2020
62020
Clustering and Classification Methods for Prediction of the risk for Developing Disease
H Lee
State University of New York at Stony Brook, 2016
2016
Comparison of longitudinal changes of cerebral small vessel disease markers and cognitive function between subcortical vascular mild cognitive impairment with and without …
CW Yoon, YE Kim, HJ Kim, CS Ki, H Lee, JH Rha, DL Na, SW Seo
Frontiers in Neurology 12, 586366, 2021
22021
Machine learning for the prediction of amyloid positivity in amnestic mild cognitive impairment
SH Kang, BK Cheon, JS Kim, H Jang, HJ Kim, KW Park, Y Noh, JS Lee, ...
Journal of Alzheimer's Disease 80 (1), 143-157, 2021
142021
Paternal age related schizophrenia (PARS): latent subgroups detected by k-means clustering analysis
H Lee, D Malaspina, H Ahn, M Perrin, MG Opler, K Kleinhaus, S Harlap, ...
Schizophrenia research 128 (1-3), 143-149, 2011
562011
Performance of the plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort
H Jang, JS Kim, HJ Lee, CH Kim, DL Na, HJ Kim, JA Allué, L Sarasa, ...
Alzheimer's Research & Therapy 13, 1-13, 2021
192021
Potential applications of artificial intelligence in clinical trials for Alzheimer’s disease
Y Seo, H Jang, H Lee
Life 12 (2), 275, 2022
122022
Predicting conversion of brain β-amyloid positivity in amyloid-negative individuals
CJ Park, Y Seo, YS Choe, H Jang, H Lee, JP Kim, ...
Alzheimer's Research & Therapy 14 (1), 129, 2022
42022
Prediction of amyloid β PET positivity using machine learning in patients with suspected cerebral amyloid angiopathy markers
YH Jung, H Lee, HJ Kim, DL Na, HJ Han, H Jang, SW Seo
Scientific Reports 10 (1), 18806, 2020
82020
Prediction of tau accumulation in prodromal Alzheimer’s disease using an ensemble machine learning approach
J Kim, Y Park, S Park, H Jang, HJ Kim, DL Na, H Lee, SW Seo
Scientific reports 11 (1), 5706, 2021
102021
Relative importance of symptoms, cognition, and other multilevel variables for psychiatric disease classifications by machine learning
J Walsh-Messinger, H Jiang, H Lee, K Rothman, H Ahn, D Malaspina
Psychiatry Research 278, 27-34, 2019
152019
Social event memory test (SEMT): a video-based memory test for predicting amyloid positivity for Alzheimer’s disease
KW Kim, JD Choi, H Lee, NK Lee, S Park, J Chin, BH Lee, J Shin, Y Kim, ...
Scientific Reports 8 (1), 10421, 2018
72018
The cortical neuroanatomy related to specific neuropsychological deficits in Alzheimer's continuum
SH Kang, YH Park, D Lee, JP Kim, J Chin, Y Ahn, SB Park, HJ Kim, ...
Dementia and neurocognitive disorders 18 (3), 77, 2019
962019
系统目前无法执行此操作,请稍后再试。
文章 1–16